The Sanofi and Glaxo SmithKline corporations will seek approval for their coronavirus vaccine candidate, officials announced on Wednesday, stating they hoped their inoculation could be used as either a standalone vaccine or a booster shot with other existing vaccines. The French-owned Sanofi Pasteur Labs, along with its British partner GlaxoSmithKline are ready to go forward […]
Read the full story on GreekReporter.com.
